Document Detail


Maternal use of Folic Acid and Other Supplements and Risk of Childhood Brain Tumors.
MedLine Citation:
PMID:  22941336     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background Interest in a possible protective effect of maternal vitamin use before or during pregnancy against childhood brain tumors (CBT) and other childhood cancers has grown over the past decade. Our Australian study of CBT, conducted between 2005 and 2011, investigated whether maternal use folic acid and other supplements was protective. Methods Case children were identified through the ten Australian pediatric oncology centers and controls were recruited by national random-digit dialing. Mothers of 327 cases and 867 control children provided information on supplement use before and during the index pregnancy, including brand name, dose and timing. Data were analysed using multivariable unconditional logistic regression. Results The odds ratios (ORs) for any maternal use of folic acid, use of folic acid without iron or vitamins B6, B12, C or A, and any vitamin use before pregnancy, were: 0.68 (95% CI 0.46, 1.00), 0.55 (95% CI 0.32, 0.93) and 0.68 (95% CI 0.46, 1.01) respectively. The ORs for use of these supplements during pregnancy were also below unity, but generally closer to the null than those for the pre-pregnancy period. There was some evidence of an inverse dose-response during each time period. Conclusions These results suggest that folic acid supplements before and possibly during pregnancy may protect against CBT. Such associations are biologically plausible through established mechanisms. Impact This study provides evidence of a specific protective effect of prenatal folic acid supplementation against the risk of CBT that is not attributable to the actions of the other micronutrients investigated.
Authors:
Elizabeth Milne; Kathryn R Greenop; Carol I Bower; Margaret Miller; Frank M van Bockxmeer; Rodney J Scott; Nicholas H de Klerk; Lesley J Ashton; Nicholas G Gottardo; Bruce K Armstrong
Related Documents :
18656076 - Contraceptive method use by adolescents in brazilian state capital.
1114506 - Oral contraceptive continuation rates in the singapore national program. 1966-1972.
9408706 - Phase ii clinical trial of a vas deferens injectable contraceptive for the male.
15036926 - I got rhythm: gershwin and birth control in the 1930s.
9650656 - Effects of antenatal thyrotropin-releasing hormone on fetal heart rate and breathing mo...
1484656 - Autoimmune diseases in pregnancy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-31
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  -     ISSN:  1538-7755     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-9-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1Population Sciences, Telethon Institute for Child Health Research.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Type 2 Diabetes Mellitus and the Incidence of Epithelial Ovarian Cancer in the Cancer Prevention Stu...
Next Document:  Neutralisation of a single voltage sensor affects gating determinants in all four pore-forming S6 se...